Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03017651 · ClinicalTrials.gov registry record · Phase 1
An Evaluation of Omega-3 Fatty Acid
A Phase 1 study, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT03017651: Completed Phase 1 study, sponsored by Société des Produits Nestlé (SPN).
NCT03017651 is a Phase 1 study that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 30 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03017651, a Phase 1 study, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
This protocol will determine the pK profile of two different omega-3 fatty acid supplements on plasma EPA and DHA levels.
Primary Outcome
The plasma pharmacokinetics (AUC0-t) resulting from a single oral dose administration will be estimated from 0 to 24 hours post-dose
Interventions
- DIETARY_SUPPLEMENT OM3-supplement 1
- DIETARY_SUPPLEMENT OM3-supplement 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-11 |
| Est. Completion | 2017-05 |
| Phase | Phase 1 |
What the finished NCT03017651 record still lists
NCT03017651 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower).
The record links to 0 conditions, and to 2 interventions - of which OM3-supplement 1 is the first listed.
NCT03017651 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03017651 about?
NCT03017651 is a clinical study titled "An Evaluation of Omega-3 Fatty Acid". This protocol will determine the pK profile of two different omega-3 fatty acid supplements on plasma EPA and DHA levels.
What is the current status of trial NCT03017651?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2016-11. Estimated completion is 2017-05.
What interventions are being tested in trial NCT03017651?
The interventions under investigation include: OM3-supplement 1 (DIETARY_SUPPLEMENT), OM3-supplement 2 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03017651?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03017651's enrollment target sits among peer trials
30 1332nd of 2000 higher than 561 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia